Lyrica is only approved for adults over 18.

WHAT TO EXPECT
WITH LYRICA

LYRICA is a daily medication that
should
be taken as prescribed by your
doctor.
Everyone is different, and
LYRICA may
take some time to
work for you.

Lyrica is only approved for adults over 18.

Doctor and patient discussing painful dpn treatment

GETTING THE MOST FROM LYRICA

Starting on LYRICA

There are things you can do when taking LYRICA (pregabalin) to get the most from your treatment. It’s important to work closely with your doctor and to keep track of how you are feeling and doing.

You may feel side effects before you start feeling better. If you are not feeling the pain relief you expect, there may be things your doctor can do to help.

GETTING TO YOUR RIGHT DOSE

Recommended LYRICA dosing

Start with 50 mg
3 times a day

(For a total of 150 mg/day)

May be increased
based on efficacy
& tolerability

Up to 100 mg
3 times a day

(For a total of 300 mg/day)

Work with your doctor to figure out the best dosage for you. Patients who do not experience sufficient diabetic nerve pain relief may be further increased up to 300 mg/day, based on efficacy and tolerability. Your doctor may continue to make adjustments according to your needs. If you have problems with kidney function, your doctor may prescribe a lower dose of LYRICA.

Man on pdpn treatment medication playing the trumpet

DID YOU KNOW

Your doctor can adjust
your dose to help
you get the most
from treatment

WHAT TO EXPECT ROADMAP

WHEN TAKING LYRICA

Across all clinical studies, side effects were generally mild to moderate. Side effects can vary from person to person, so make sure to talk with your doctor about any side effects you may be experiencing.

Weeks

1-2 weeks

In clinical trials, some patients started feeling less diabetic nerve pain as early as the 1st week of treatment. For others, it took longer and individual results may vary.

It’s possible you may begin to feel side effects within the first week. The 2 most common side effects of LYRICA are dizziness and sleepiness. Across all clinical studies, dizziness occurred in 30% of LYRICA patients, compared with 8% of patients taking a placebo, and on average, lasted about 1 to 2 weeks. For some people, this went away over time. For others, these side effects lasted throughout the course of the studies.

If you do experience side effects, your doctor can adjust your dose or provide recommendations to help. Click here to learn more about sleepiness in clinical studies.

After the 1st week of treatment, your doctor may increase your dose based on the efficacy of LYRICA and how well you may tolerate it. Of course, your doctor will make adjustments based on how you’re feeling in regard to both pain relief and side effects. It’s not recommended that you take more than 300 mg of LYRICA per day for diabetic nerve pain.

3-4 weeks

After the first few weeks of taking LYRICA, follow up with your doctor and start discussing your complete treatment plan, and get any refills you may need.

This is the right time for you to discuss with your doctor how you are doing and any side effects you may feel.

Everyone is unique and may respond to LYRICA differently. LYRICA is available in multiple strengths. Your doctor can adjust your dose to help you get the most from treatment.

5 weeks+

After 1 to 2 months of taking LYRICA, be sure to continue to keep your doctor informed. This will enable you both to decide the best course of action to help you get the most from your treatment.

Sleepiness occurred in 23% of LYRICA patients, compared with 8% of patients taking a placebo, and on average, lasted about 4 to 6 weeks. For some people, these went away over time. For others, these side effects lasted throughout the course of the studies.

TALKING TO YOUR DOCTOR

Get helpful tips on how to
talk to your doctor about
diabetic nerve pain

Start Here

TERMS AND CONDITIONS

OFFER TERMS AND CONDITIONS

By using the Co-Pay Savings Card, you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions:

Patients are not eligible to use this card or participate in this program if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veteran Affairs healthcare, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”). Patient must have private insurance. Offer is not valid for cash paying patients. The value of this card is limited to $175 per month per prescription (“offering period”) or the amount of your co-pay, whichever is less (Maximum annual savings of $2100). This program is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plan or other private health or pharmacy benefit programs. You must deduct the value received under this program from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf. You are responsible for reporting use of this program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay cards. You must be 18 years of age or older to accept this offer. This offer is not valid where prohibited by law.

For Massachusetts residents:

This co-pay offer is not valid if an A/B generic is available for Massachusetts residents whose prescriptions are covered in whole or in part by third-party insurance.

For California residents:

This co-pay offer is not valid if a generic is available for California residents whose prescriptions are covered in whole or in part by third-party insurance.

Please check with your healthcare professional or insurer to confirm eligibility. This offer cannot be combined with any other savings, free trial or similar offer for the specified prescription. The co-pay card will be accepted only at participating pharmacies. The co-pay card is not health insurance. Offer good only in the U.S. and Puerto Rico. The co-pay card is limited to one per person during this offering period and is not transferable. A co-pay card may not be redeemed more than once per offering period per patient. No other purchase is necessary. Data related to your redemption of the co-pay card may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer’s programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other co-pay card redemptions and will not identify you. Pfizer reserves the right to rescind, revoke or amend this offer without notice. No membership fee. For more information, visit our website www.lyrica.com, call 1-866-954-1475, or contact us at 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560.

Offer expires 12/31/2020.

For reimbursement when using a nonparticipating pharmacy/mail order:

Pay for prescription, and mail copy of original pharmacy receipt (cash register receipt NOT valid) with product name, date, and amount circled to: Co-Pay Savings Card, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560. Be sure to include a copy of the front of your activated Co-Pay Savings Card, your name and mailing address.

MOBILE PROGRAM TERMS AND CONDITIONS

By opting into the Pfizer LSAVINGS Mobile program (“Program”), in which you can receive your Co-Pay Savings Card via text, you consent to receive approximately 5 text messages and/or push notifications per month from Pfizer Inc. Consent is not a condition of purchase or use of any Pfizer product or service. Such messages may be marketing or non-marketing messages and may include, for example, refill reminders, fill confirmation, website information, etc. T-Mobile is NOT liable for delayed or undelivered messages.

To stop receiving text messages, text STOP to 597422. DOING SO WILL ONLY OPT YOU OUT OF THE LSAVINGS MOBILE PROGRAM; you will remain opted in to any other Pfizer Inc. text message program(s) to which you separately opted in. You may unsubscribe from the digital wallet message Program at any time by disabling push notifications or removing the digital wallet pass from your device for digital wallet programs.

To request more information or to obtain help, text HELP to 597422. You can also call customer service at 1-877-822-7855.

You represent that you are the account holder for the mobile telephone number(s) that you provide to opt in to the texting Program. You are responsible for notifying Pfizer Inc. immediately if you change your mobile telephone number. You may notify Pfizer Inc. of a number change by re-enrolling in the Program.

Message and data rates may apply to each text message sent or received in connection with the texting Program, as provided in your mobile telephone service rate plan, in addition to any applicable roaming charges. Charges are both billed and payable to your mobile service provider or deducted from your prepaid account. Pfizer Inc. does not impose a separate fee for sending text messages.

Data obtained from you in connection with this Short Message Service (SMS) texting program may include your telephone number; your carrier’s name; and the date, time, and content of your messages. Pfizer Inc. may use this information to contact you and to provide the services you request from us.

You understand that data obtained from you in connection with your registration for, and use of, the Program may include, for example, your phone number, related carrier information, device information, and elements of pharmacy claim information. This data may be used to administer this Program and to provide Program benefits such as savings offers, information about your prescription, refill reminders, as well as Program updates and alerts sent directly to your device. Please read our full corporate Privacy Policy, which is incorporated by reference into these Terms.

In addition to the data use practices described in the Privacy Policy, we may send you offer-related push notifications when your device is in the physical proximity of your pharmacy or healthcare provider. This is done through geofencing technology, which is built in to your device. Your device’s location will not be known or tracked by Pfizer or its service providers. Nonetheless, you may opt out of geofencing and receiving these notifications at any time by (1) disabling location services for your digital wallet app in your device’s settings, (2) disabling notifications (i.e., automatic updates) within the digital wallet app, or (3) removing the eCard from your digital wallet by selecting “Remove Pass” within the digital wallet app.

Pfizer Inc. will not be liable for any delays in the receipt of any SMS messages, as delivery is subject to effective transmission from your network operator.

The service is available only on these US participating mobile carriers: Verizon Wireless, Sprint, Nextel, Boost Mobile, T-Mobile, AT&T, Alltel, ACS Wireless, Bluegrass Cellular, Carolina West Wireless, Cellcom, Cellular One of East Central Illinois (ECIT), Cincinnati Bell, Cricket Wireless, C Spire Wireless, Duet IP (AKA Max/Benton/Albany), Element Mobile, Epic Touch, GCI Communication, Golden State Cellular, Hawkeye (Chat Mobility), Hawkeye (NW Missouri Cellular), Illinois Valley Cellular (IVC), Inland Cellular, iWireless, Keystone Wireless (Immix/PC Management), MetroPCS, Mobi PCS, Mosaic Telecom, MTPCS/Cellular One (Cellone Nation), Nex-Tech Wireless, nTelos, Panhandle Telecommunications, Pioneer, Plateau, Revol Wireless, Rina-Custer, Rina-All West, Rina-Cambridge Telecom Coop, Rina-Eagle Valley Comm, Rina-Farmers Mutual Telephone Co, Rina-Nucla Nutria Telephone Co, Rina-Silver Star, Rina-South Central Comm, Rina-Syringa, Rina-UBET, Rina-Manti, Simmetry Wireless, South Canaan (Cellular One of NEPA), Thumb Cellular, Union Wireless, United Wireless, U.S. Cellular, Viaero Wireless, Virgin Mobile, and West Central Wireless (includes Five Star Wireless).

You agree to indemnify Pfizer Inc. and parties texting on its behalf in full for all claims, expenses, and damages related to or caused in whole or in part by your failure to notify us if you change your telephone number, including but not limited to all claims, expenses, and damages related to or arising under the Telephone Consumer Protection Act.

Pfizer Inc. may suspend or terminate your receipt of text messages if it believes you are in breach of these SMS Terms and Conditions. Your receipt of text messages is also subject to termination in the event that your mobile telephone service terminates or lapses. Pfizer Inc. reserves the right to modify or discontinue, temporarily or permanently, all or any part of the text messaging services you receive, with or without notice.

Pfizer Inc. may revise, modify, or amend these SMS Terms and Conditions at any time. Any such revision, modification, or amendment shall take effect when it is posted to Pfizer Inc.’s website. You agree to review these SMS Terms and Conditions periodically to ensure that you are aware of any changes. Your continued consent to receive text messages will indicate your acceptance of those changes.

E-MAIL TERMS AND CONDITIONS

By agreeing to the terms of LSAVINGS E-mail program (the “E-mail Program”), you consent to receive e-mail messages on behalf of Pfizer. Consent is not a condition of purchase or use of any Pfizer product or service.

Data obtained from you in connection with your registration for, and use of, the E-mail Program may include your e-mail address and elements of pharmacy claim information, such as name, date of birth, and prescription information. You agree that such data may be used to administer the E-mail Program and to provide E-mail Program benefits such as savings offers, information about your prescription, including refill reminders and new prescription requests, as well as E-mail Program updates and alerts sent directly to your e-mail address.

You may unsubscribe from the E-mail Program at any time by clicking on the unsubscribe link at the bottom of any E-Mail Program e-mail. Please do not reply to E-mail Program e-mails as it is an unattended e-mail box. A link to contact Pfizer is at the bottom of every E-mail Program e-mail. Pfizer reserves the right to rescind, revoke, or amend the E-mail Program without notice.